| Literature DB >> 32575468 |
Krishnapriya Thiyagarasaiyar1, Bey-Hing Goh2,3,4, You-Jin Jeon5, Yoon-Yen Yow1.
Abstract
Cosmetics are widely used by people around the world to protect the skin from external stimuli. Consumer preference towards natural cosmetic products has increased as the synthetic cosmetic products caused adverse side effects and resulted in low absorption rate due to the chemicals' larger molecular size. The cosmetic industry uses the term "cosmeceutical", referring to a cosmetic product that is claimed to have medicinal or drug-like benefits. Marine algae have gained tremendous attention in cosmeceuticals. They are one of the richest marine resources considered safe and possessed negligible cytotoxicity effects on humans. Marine algae are rich in bioactive substances that have shown to exhibit strong benefits to the skin, particularly in overcoming rashes, pigmentation, aging, and cancer. The current review provides a detailed survey of the literature on cosmeceutical potentials and applications of algae as skin whitening, anti-aging, anticancer, antioxidant, anti-inflammation, and antimicrobial agents. The biological functions of algae and the underlying mechanisms of all these activities are included in this review. In addition, the challenges of using algae in cosmeceutical applications, such as the effectiveness of different extraction methods and processing, quality assurance, and regulations concerning extracts of algae in this sector were also discussed.Entities:
Keywords: UV-radiation; anti-aging; anticancer; cosmeceuticals; marine algae; skin whitening
Mesh:
Substances:
Year: 2020 PMID: 32575468 PMCID: PMC7344841 DOI: 10.3390/md18060323
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Effect of UV radiation-induced reactive oxygen species (ROS). Accumulation of ROS leads to skin cancer, inflammation, photoaging, wrinkling, and melanogenic through activation of respective signaling pathways.
Figure 2Distribution of algae species from different phyla in cosmeceuticals. The review was based on three major databases of ScienceDirect, PubMed, and Google Scholar.
Figure 3Distribution of algae-derived extracts or compounds with cosmeceutical properties. The result is based on 122 algae species (Some of the algae contribute to more than one biological functions).
Bioactive compounds derived from algae and their applications in cosmeceuticals.
| Algae Species | Bioactive Compound/Extract | Beneficial Activity | Mechanism of Action | Experimental Model | Reference |
|---|---|---|---|---|---|
|
| |||||
| | Ascophyllan | Anticancer | Inhibit MMP expression | B16 melanoma cells | [ |
| | Eleganonal | Antioxidant | DPPH inhibition | In vitro | [ |
| | Ethanol extract | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Fucoidan | Anti-inflammation | Inhibition of LPS-induced NO production, iNOS, COX-2, and PGE2 levels | RAW macrophages | [ |
| | Fucoxanthin | Antioxidant | DPPH inhibition | In vitro | [ |
| | Ethanol extract | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Fat-soluble vitamin and carotenoids | Antioxidant | High fat-soluble vitamin and carotenoid content | In vitro | [ |
| | Polyphenol | Antioxidant | DPPH inhibition (EC50 = 5.27 mg/mL) | In vitro | [ |
| | Phenol and fucoxanthin | Antioxidant | High total phenolic and fucoxanthin content | In vitro | [ |
| | Ethanol extract | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Ethanol extract | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Algae extract | Antimicrobial | Inhibit the synthesis of the peptidoglycan layer of bacterial cell walls | [ | |
| | Dieckol | Anti-inflammation | Suppression of iNOS and COX-2 | Murine BV2 microglia | [ |
| Phlorotannin | Anti-melanogenic | Inhibit melanin production | B16F10 melanoma cells | [ | |
| Phlorotannin | Antioxidant | ROS scavenging potential | Chinese hamster lung fibroblast (V79-4) | [ | |
| | Phlorotannin | Anti-inflammation | Inhibit hyaluronidase | Assay of HAase (In vitro) | [ |
| | Phlorotannin | Anti-aging | Inhibit MMP expression | Human dermal fibroblast cell | [ |
| Phlorofucofuroeckol A and B | Anti-inflammation | Inhibition of NO production by downregulating iNOS and prostaglandin E2 | LPS stimulated RAW 264.7 cells | [ | |
| | Phlorotannin | Anti-inflammation | Inhibit release of histamine | Rat basophile leukemia cells (RBL-2HE) | [ |
| | Phlorotannin | Anti-inflammation | Inhibit hyaluronidase | Assay of HAase (In vitro) | [ |
| | Fucoidan | Anticancer | Inhibit cell proliferation | Human malignant melanoma cells | [ |
| | Extract | Anti-aging | Stimulate collagen production | N/A | [ |
| Fucoidan | Anti-melanogenic | Inhibit tyrosinase and melanin | B16 murine melanoma cells | [ | |
| Fucoidan | Anticancer | Decrease melanoma growth | Mice | [ | |
| Fucoxanthin | Antioxidant | Prevent oxidation formation | In vitro, RAW 264.7 macrophage, Mouse (ex vivo) | [ | |
| | Ethanol extract | Anti-inflammation | COX-2 inhibition | COX inhibitory screening assay kit | [ |
| | Fatty acid andPhenol | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Fucosterol | Anti-aging | Inhibit MMP expression | Human dermal fibroblast | [ |
| Ethyl acetate extract | Anti-melanogenic | Inhibit tyrosinase and melanin | B16F10 mouse melanoma cells | [ | |
| Fucoxanthin | Antioxidant | DPPH inhibition | In vitro | [ | |
| | Ethanol extract | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Phlorotannin | Anti-melanogenic | Downregulation of tyrosinase and melanin synthesis | B16F10 cells | [ |
| | Diphlorethohydroxycarmalol | Anti-inflammation | Down-regulation of iNOS and COX-2 expression and NF-κβ activation | Human umbilical vein endothelial cells | [ |
| | Fucoxanthin | Anti-melanogenic | Suppress tyrosinase activity | UVB- irradiated guinea pig | [ |
| | Polyphenol | Antioxidant | High total phenolic content and antioxidant capacity | In vitro | [ |
| | Phlorotannin | Antioxidant | ROS scavenging potential | In vitro | [ |
| Hyaluronic acid | Anti-aging | Enhance the production of syndecan-4 | N/A | [ | |
| | Ethanol extract | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Polyphenol | Antimicrobial | Bacterial growth inhibition | [ | |
| Acetone extract | Antioxidant | Free radical scavenging activity (IC50 = 691.56 µg L−1) | In vitro | [ | |
| | Diterpenes | Antioxidant | DPPH (IC50 = 1.73) & ABTS (IC50 = 2.01) inhibitions | In vitro | [ |
| Sulfated polysaccharide | Anti-inflammation | COX-2 and iNOS inhibitions | Paw edema in rats | [ | |
| | Ethanol extract | Anti-melanogenic | Inhibit tyrosinase and melanin | B16F10 murine melanoma cells | [ |
| Aqueous extract | Antioxidant | DPPH inhibition | In vitro | [ | |
| | Ethanol extract | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Phenol | Antioxidant | High total phenolic content, DPPH scavenging activity and FRAP | In vitro | [ |
| | Fucoxanthin | Antioxidant | DPPH inhibition | In vitro | [ |
| | Methanol extract | Antioxidant | DPPH (EC50 = 0.461) & ABTS (EC50 = 0.266) inhibitions | In vitro | [ |
| | Sulfated polysaccharide | Anti-inflammation | Inhibit LPS-induced inflammatory response | RAW 264.7 macrophage cells | [ |
| | Sulfated polysaccharide | Anticancer | Activation of caspase-3 | B16 melanoma cells | [ |
| | Ethanol extract | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Sargachromanol.E | Anti-aging | Inhibit MMP expression | UVA irradiated dermal fibroblast | [ |
| Alginic acid | Anti-inflammation | Inhibit inflammatory response | HaCaT cells | [ | |
| | Tetraprenyltoluquinol chromane meroterpenoid | Anti-aging | ROS scavenging potential | Human dermal fibroblast | [ |
| | Ethanol extract | Anti-melanogenic | Inhibit tyrosinase and melanin production | B16F10 melanoma cells | [ |
| | Sargachromenol | Anti-melanogenic | Downregulation of microphthalmia-associated transcription factor | B16F10 melanoma cells | [ |
| | Fucoxanthin | Antioxidant | Reduced UVB-induced ROS production | Human fibroblast | [ |
| | Thunbergols | Antioxidant | DPPH inhibition | In vitro | [ |
| | Methanol extract | Antioxidant | β-carotene bleaching activity | In vitro | [ |
| | Spatane diterpenoids | Anticancer | Cell growth inhibition | Murine B16F10 melanoma cells | [ |
| | Laminarin, alginate, fucoidan | Antioxidant | ROS scavenging potential | N/A | [ |
| | Fucoxanthin | Antioxidant | High FRAP value (>10 µM/µg of extract) | In vitro | [ |
| | Fucoxanthin | Anti-aging | MMP expression reduction, VEGF | Mouse | [ |
| Ethyl acetate extract | Anti-melanogenic | Down regulate melanin and inhibit tyrosinase | Mouse B16 melanoma cells | [ | |
| Polyunsaturated fatty acid | Anti-inflammation | N/A | Mouse ear edema and erythema | [ | |
| Fucoxanthin | Antioxidant | DPPH inhibition | In vitro | [ | |
|
| |||||
| | Methanol extract | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Algae extract | Antioxidant | Induce peroxidase and superoxide dismutase to reduce oxidative stress | In vitro | [ |
| | Methanol extract | Antioxidant | DPPH (EC50 = 0.357) & ABTS (EC50 = 0.370) inhibitions | In vitro | [ |
| | Methanol extract | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Methanol extract | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Polysaccharide | Antioxidant | DPPH inhibition | In vitro | [ |
| | Aqueous extract | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Methanol extract | Anti-aging | Reduce the expression of gelatinase | Human dermal fibroblast | [ |
| | Ethanol extract | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Ethanol extract | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Fat-soluble vitamin and carotenoids | Antioxidant | High fat-soluble vitamin and carotenoid content | In vitro | [ |
| | Ethanol extract | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Phenol | Antioxidant | ROS scavenging potential | In vitro | [ |
| | Sulfated polysaccharide | Antioxidant | DPPH, Superoxide radical assay, hydroxyl radical assay (EC50 = 2.45 mg/mL) | In vitro | [ |
| | 2H- chromenyl | Antioxidant | DPPH and ABTS inhibitions | In vitro | [ |
| | Glycosaminoglycan | Anti-aging | Collagen synthesis | Unknown | [ |
| | Phenol | Antioxidant | DPPH inhibition | In vitro | [ |
| | Sesquiterpenes | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Polysaccharide | Antioxidant | DPPH (IC50 = 24 µg/mL), FRAP (IC50 = 92 µg/mL), | In vitro | [ |
| | Laurinterol | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Sesquiterpenes | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Glycosaminoglycan | Anti-aging | Collagen synthesis | Unknown | [ |
| | Methanol extract | Antioxidant | DPPH (EC50 = 0.041 mg/mL), ABTS (EC50 = 0.031 mg/mL), Metal chelating (EC50 = 0.1 mg/mL), folin ciocalteu (EC50 = 0.128 mg/mL) | In vitro | [ |
| | Methanol extract | Antioxidant | β-carotene bleaching activity | In vitro | [ |
| | MAA | Anti-aging | Collagenase inhibition |
| [ |
| | Fucoxanthin | Antioxidant | High FRAP value | In vitro | [ |
| | Sulfated Polysaccharide | Antioxidant | ROS scavenging potential | Mice | [ |
| | MAA | Anti-aging | Control expression of MMP | Human dermal fibroblast | [ |
| | MAA | Anti-aging | Collagenases inhibition |
| [ |
| | MAA | Antioxidant | ROS scavenging potential and MMP expression | Human skin fibroblast | [ |
|
| Sulfated polysaccharide | Antimicrobial | N/A |
| [ |
|
| Phenol | Antioxidant | DPPH, β-carotene bleaching and ABTS inhibitions |
| [ |
| | Polysaccharide | Anti-aging | Promote collagen synthesis | Human dermal fibroblast | [ |
| | Polyphenol | Antimicrobial | Bacterial growth inhibition | [ | |
| Bromophenol | Antioxidant | DPPH inhibition | In vitro | [ | |
| | Phenol | Anti-melanogenic | Inhibit tyrosinase activity | In vitro | [ |
|
| |||||
| | Polysaccharide | Antioxidant | ROS scavenging potential | In vitro | [ |
| | Fucoxanthin | Antioxidant | DPPH inhibition (63.77%) | In vitro | [ |
| | MAA | Antioxidant | ROS scavenging potential | In vitro | [ |
| | Ethanol extract | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Ethanol extract | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Ethanol extract | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Sterol | Anti-inflammation | Reduces the expression of COX-2, iNOS, and TNF-α | Mice | [ |
| | Ethanol extract | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Chloroform and methanol extract | Antioxidant | SOD activity is reduced |
| [ |
| | Polysaccharide | Antioxidant | ROS scavenging potential | In vitro | [ |
| | Fucoxanthin | Antioxidant | High FRAP value | In vitro | [ |
| | Ethanol extract | Antimicrobial | Bacterial growth inhibition |
| [ |
|
| Fucoxanthin | Antioxidant | DPPH inhibition (83.95%) | In vitro | [ |
| | Phycocolloids | Anti-inflammation | N/A | N/A | [ |
| | Polysaccharide | Antioxidant | ROS scavenging potential | In vitro | [ |
| | Phenol and flavonoid | Antioxidant | DPPH inhibition, high phenolic and flavonoid contents | In vitro | [ |
| | Phenol | Antioxidant | DPPH inhibition | In vitro | [ |
| | Sulfated polysaccharide | Anti-aging | Increase hyaluronan production | Human dermal fibroblast | [ |
|
| |||||
| | Lycopene | Antioxidant | N/A | In vitro | [ |
| | Methanol extracts of exopolysaccharides | Antioxidant | N/A | In vitro | [ |
| | Sporopollenin | Anti-aging | Protect cells from UV radiation | N/A | [ |
| | MAA | Anti-aging | Protect cells from UV radiation | N/A | [ |
| | MAA | Anti-aging | Protect cells from UV radiation | N/A | [ |
| Lutein | Anti-aging | Reduce UV induced damage | N/A | [ | |
| | Hot water extract | Anti-aging | Reduced activity of SOD | Human diploid fibroblast | [ |
| Anti-inflammation | Downregulated mRNA expression levels of IL-4 and IFN-γ | NC/Nga mice | [ | ||
| | β-carotene | Antioxidant | Protect against oxidative stress | Rat | [ |
| β-cryptoxanthin | Anti-inflammation | Reduced the production of IL-1 | LPS-stimulated RAW 264.7 cells | [ | |
| | Astaxanthin (carotenoid) | Anti-aging | Inhibit MMP expression | Mice and human dermal fibroblasts | [ |
| Anticancer | ROS scavenging potential | Mice | [ | ||
| | Carotenoid | Antioxidant | DPPH inhibition | In vitro | [ |
| | Zeaxanthin | Anti-melanogenic | Inhibit tyrosinase | In vitro | [ |
| | Fucoxanthin | Antioxidant | Reduced oxidative stress | Human Glioma Cells | [ |
| | MAA | Antioxidant | ROS scavenging potential | In vitro | [ |
| | EPA | Antioxidant | Reduce oxidative stress | Rat | [ |
| | Fatty acid | Antimicrobial | Bacterial growth inhibition |
| [ |
| | Sulfated polysaccharide | Anti-inflammation | Inhibit proinflammatory modulator | Unknown | [ |
| | Sulfated polysaccharide | Antioxidant | ROS scavenging potential | In vitro | [ |
| | Polyunsaturated aldehyde and fatty acid | Anticancer | Inhibit cell proliferation | Human melanoma cells (A2058) | [ |
| | β-carotene and phycocyanin | Antioxidant | Inhibit lipid peroxidation | MouseHuman | [ |
| Ethanol extract | Antimicrobial | Bacterial growth inhibition | [ | ||
| | Fatty acids and phenols | Antimicrobial | Bacterial growth inhibition |
| [ |
Figure 4Chemical structures of bioactive compounds derived from algae. (1) Eckol, (2) Fucosterol, (3) Diphlorethohydroxycarmalol, (4) Mycosporine-glycine, (5) Eleganonal, (6) Phenol, (7) Ascophyllan, (8) Laurinterol, (9) Fucoidan, (10) Eicosapentaenoic acid, (11) Lutein, (12) Sargachromanol E, (13) Fucoxanthin, (14) Astaxanthin, (15) Zeaxanthin, and (16) Lycopene.